Institutional investors purchased a net $1.6 million shares of IMMU during the quarter ended December 2014, and now own 42.29% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
TFS CAPITAL LLC Bought 590.1 Thousand shares of Immunomedics Inc
THE VANGUARD GROUP, INC. Bought 470.8 Thousand shares of Immunomedics Inc
BLACKROCK FUND ADVISORS Bought 296.8 Thousand shares of Immunomedics Inc